PR
Praxis Precision Medicines, Inc.
PRAX · NASDAQ
$298.87 -1.77% (-$5.40)
1M -18.79%
Market Cap $8.66B
P/E Ratio -
Div. Yield -
ROE 34.15%
Bulios Fair Price
$227.33
23.9% downside
Current Price
$298.87
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PRAX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
19 /100
Expensive P/B 6.45x
P/FFO N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 125.97%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 34.15%
ROA 24.40%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 15.73x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
15 /100
Unstable EPS volatility 54.46%
Profitable years 0
Beta 2.78x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PRAX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marcio Silva De'Souza
Employees
168
Headquarters
Boston
Upcoming events
09 NOV
Earnings
Upcoming earnings report